Clearwater Capital Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Hold |
846,419
| – | – | 0.2% | 52 |
|
|
2025
Q1 | $2.55M | Hold |
846,419
| – | – | 0.25% | 50 |
|
|
2024
Q4 | $2.17M | Buy |
846,419
+363,870
| +75% | +$932K | 0.21% | 55 |
|
|
2024
Q3 | $1.8M | Hold |
482,549
| – | – | 0.17% | 59 |
|
|
2024
Q2 | $3.05M | Buy |
482,549
+39,250
| +9% | +$248K | 0.32% | 45 |
|
|
2024
Q1 | $2.38M | Hold |
443,299
| – | – | 0.25% | 52 |
|
|
2023
Q4 | $2.23M | Buy |
443,299
+48,700
| +12% | +$244K | 0.25% | 51 |
|
|
2023
Q3 | $667K | Hold |
394,599
| – | – | 0.08% | 69 |
|
|
2023
Q2 | $1.1M | Buy |
394,599
+77,448
| +24% | +$215K | 0.13% | 63 |
|
|
2023
Q1 | $577K | Buy |
317,151
+131,240
| +71% | +$239K | 0.07% | 83 |
|
|
2022
Q4 | $943K | Hold |
185,911
| – | – | 0.12% | 71 |
|
|
2022
Q3 | $924K | Buy |
185,911
+600
| +0.3% | +$2.98K | 0.13% | 78 |
|
|
2022
Q2 | $689K | Buy |
185,311
+37,420
| +25% | +$139K | 0.09% | 81 |
|
|
2022
Q1 | $830K | Buy |
147,891
+7,340
| +5% | +$41.2K | 0.1% | 81 |
|
|
2021
Q4 | $855K | Sell |
140,551
-7,340
| -5% | -$44.7K | 0.09% | 89 |
|
|
2021
Q3 | $1.44M | Buy |
147,891
+75,865
| +105% | +$739K | 0.17% | 65 |
|
|
2021
Q2 | $1.03M | Hold |
72,026
| – | – | 0.12% | 75 |
|
|
2021
Q1 | $1.71M | Buy |
72,026
+37,971
| +111% | +$901K | 0.21% | 59 |
|
|
2020
Q4 | $454K | Buy |
+34,055
| New | +$454K | 0.06% | 104 |
|